DPP4 and type 2 diabetes mellitus: In the present study, we analyzed Taiwan’s multi-institutional electronic medical records to compare head-to-head the glucose-lowering effects of SGLT2 inhibitors vs. DPP4 inhibitors in type 2 diabetes patients.